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Cesarean scar pregnancy (CSP) is a potentially dangerous, iatrogenic consequence 
of a previous cesarean section (CS). If missed or inadequately managed, CSP can 
lead to severe maternal complications in any trimester of pregnancy.1 
 
Pathophysiology of CSP 
A CSP occurs when the pregnancy implants on the uterine scar, usually from a 
previous CS. It is suggested that decidual defect following the iatrogenic creation of a 
CS scar has an adverse effect on early implantation. There are several risk factors 
discussed in the literature that may predispose persistent uterine scar defects after CS. 
The impact of single- versus double-layer closure of the uterine incision on scar defects 
is still unknown. Sardo et al. concluded in his systematic review that the incidence of 
Scar defects and uterine dehiscence in a subsequent pregnancy are similar for single 
versus double layer closure following a CS2. In contrast, Bij de Vate et al. suggested 
that single-layer closure might be a risk factor for developing a niche3. Of interest is 
also the impact of cervical dilatation on the healing of the scar. In a study with 409 
women, the residual myometrial thickness over the scar was significantly reduced in 
women that had a cesarean section performed in the second stage of labour as 
compared to first stage of labour4. A thin myometrium is significantly associated with 
the occurrence of scar defects4. In another large cohort study of 371 women, the 
following were risk factors for scar defects: gestational diabetes with an OR 1.73 (95% 
CI 1.02-2.92, P = .042), previous CS OR 3.14 ( 95% C.I. 1.90-5.17; P < .001), and 
advanced maternal body mass index  1.06 (95% C.I. 1.01-1.11; P = .012)5. In a large 
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Chinese study with 514 women, perioperative fever and infection were also associated 
with scar defects6.  
Presumably, the implantation of the conceptus in a subsequent pregnancy into the 
uterine niche/scar is a random occurrence and leads to the development of CSP. 
 
Prevalence of CSP 
There is a wide range in the prevalence of scar niches described in the literature. In a 
random population of women with previous CS, the prevalence of CSP was found to 
vary between 56% and 84%, using contrast-enhanced sonohysterography3. The 
estimated prevalence of CSP is 1 in 1500/2000 women with previous CS1. Looking into 
placenta accreta, there is a wide variation in reported prevalence, ranging between 1 
in 300 and 1 in 2000 pregnancies7. In a systematic review including 14 cohort studies 
with 3889 pregnancies found a pooled incidence of placenta previa accreta of 4.1% in 
women with 1 prior cesarean and 13.3% in women with ≥2 previous cesarean 
deliveries. Even though the overall prevalence of CSP is very low, the incidence is 
significantly increased when both CS in the previous pregnancy and a low-lying 
placental position in the current pregnancy are diagnosed. 
 
Natural history of CSP 
A number of early, 1st trimester CSPs will spontaneously demise much like some 
intrauterine and ectopic gestations. Some patients may select ending the pregnancy 
after being counseled about the possibility of serious complications in the second and 
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third trimester. If the pregnancy is continued and abnormal invasion of the placenta 
(AIP) develops (Figure 1), these pregnancies may lead to significant and serious 
maternal morbidity such as vaginal or intraabdominal bleeding, uterine rupture and 
shock. In a systematic review of 17 studies of 69 cases of CSP managed expectantly, 
13% experienced an uncomplicated miscarriage, uterine rupture during the first or 
second trimester of pregnancy occurred in 10% and 77% of women progressed to the 
third trimester of pregnancy - of whom 39% experienced severe bleeding with a high 
rate of AIP diagnosis8. Despite the maternal morbidity associated with continuing a 
CSP, the majority (~75%) of pregnancies complicated by CSP may progress to term 
and result in live birth, thus questioning whether early termination of pregnancy should 
be the only therapeutic option offered to these women.  
 
Diagnosis of CSP and AIP 
The best imaging modality to diagnose a CSP is transvaginal ultrasound (US)9. The 
diagnostic criteria include an empty uterine cavity, an empty and closed endocervical 
canal and the visualization of a gestational sac implanted anteriorly in the area of the 
scar, at the level of the internal os, negative sliding organ sign (gentle pressure with 
the vaginal probe does not displace the gestational sac from its position), and 
increased placental vascularity (typically with high blood flow velocity 20cm/s and low 
impedance PI<1)1, 9. It is very important to record the position of the placenta and 
gestational sac. Jurkovic showed before that vascularity of the pregnancy on Doppler 
examination and gestational age were the most significant predictors of excessive 
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blood loss10. An early diagnosis of a CSP allows timely management. Missed 
diagnoses of CSP reported in the literature are high. In a review, of 751 cases of CSP 
107 (13.6%) were missed or misdiagnosed resulting in a large number of bleeding 
complications, some as severe requiring hysterectomy. Signs of abnormal invasion of 
the placenta can already be detected in the first trimester of pregnancy. Kaelin Agten 
showed that CSP implanted in a defect scar resulted in more severe AIP and Cali 
showed that the relationship between the gestational sac and the endometrial line 
(cross-over sign) in CSP was useful in predicting the evolution of CSP towards different 
types of AIP11, 12. Ultrasound has a good diagnostic accuracy to detect an abnormally 
invasive placenta (AIP) in the first trimester. At least one US sign suggestive of AIP 
was detected in 83.7% (95% CI 61.3-97.5) of cases with the confirmed diagnosis13. US 
signs of AIP are also used to describe CSP, as the are from the same histo-
pathologically disease spectrum14. According to Jauniaux, the incidence of AIP was 
4.1% in women with 1 prior cesarean and 13.3% in women with ≥2 previous CS15. 
Therefore, screening for AIP in early pregnancy is recommended16. 
 
Management of CSP 
To date, there is no standardized treatment protocol agreed or available17. Surgical 
approaches for pregnancy interruption include dilatation & curettage, laparoscopy, 
hysteroscopy or laparotomy. Medical therapies may be affected with systemic 
administration of methotrexate or ultrasound-guided local intragestational sac injection 
of methotrexate or potassium chloride. However, the success rate of the latter in 
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avoiding serious maternal complications with a fetal heartbeat is uncertain. As a result, 
occasionally physicians advocate an interventional radiology approach to embolize a 
CSP. In many centers, a conservative approach is adopted often inadvertently through 
missed diagnosis or intentionally through maternal choice for a much-wanted 
pregnancy despite the risks of maternal morbidity. 
 
Justification for an international registry 
There is general consensus that a low implantation in a uterus previously scarred by 
CS predisposes to CSP. Physicians also acknowledge that even though a rare 
diagnosis, CSP results in early pregnancy uterine rupture/hemorrhage or term AIP with 
significant maternal morbidity. The lack of agreed clinical screening protocols and 
relatively infrequent US diagnosis result in a paucity of data regarding the true natural 
history and data to support the optimal management of this condition. What data is 
available and published come from small retrospective clinical series or those that are 
influenced by referral bias. Consequently, there is wide variation in practice in the 
management of CSP from routine early termination of pregnancy to expectant 
management and planned Cesarean hysterectomy in the late third trimester. 
We propose and funded an international CSP registry to prospectively collate the 
diagnosis, natural history, variation in surgical/medical practice, maternal 
complications and pregnancy outcome. Cases can be uploaded by participating 
doctors upon registration on www.csp-registry.com (Figure 2).  We invite doctors with 
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CSP cases to upload pregnancy data onto the registry in order to facilitate collation of 
knowledge and produce the best evidence for diagnosis and treatment of CSP. 
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Figure legends 
Figure 1. Evolution of a cesarean scar pregnancy. 
Figure 2. QR code to access CSP-registry 
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